Ignite Creation Date:
2025-12-24 @ 5:31 PM
Ignite Modification Date:
2026-01-25 @ 7:01 AM
Study NCT ID:
NCT04985968
Status:
TERMINATED
Last Update Posted:
2023-12-27
First Post:
2021-07-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The Efficacy and Safety of Cobitolimod in Participants With Moderate to Severe Active Left-Sided Ulcerative Colitis
Sponsor:
InDex Pharmaceuticals
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Ulcerative Colitis | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Colitis, Ulcerative | View |
| None | Gastrointestinal Disease | View |
| None | Inflammatory Bowel Diseases | View |
| None | Glucocorticosteroids | View |
| None | Anti-Inflammatory Agents | View |
| None | Therapeutic uses | View |
| None | Cobitolimod | View |
| None | Toll like receptor 9 agonist | View |
| None | TLR9 agonist | View |
| None | Kappaproct | View |
| None | IDX0150 | View |
| None | DIMS0150 | View |